Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

She left the agency saying politics had slowed the approval of the morning-after pill for over-the-counter use. Her ...

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

A Clarksville man was charged with drug possession in Oak Grove Thursday. Oak Grove Police say they stopped a vehicle driven ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

And both the Trump and Biden White Houses vetted communications related to COVID-19 at various points in the pandemic. Mitch Zeller, who was director of the FDA’s Center for Tobacco Products ...

The Los Angeles Times had an insightful article on the barriers to change and political threats the agency faces -- from the outgoing commissioner just before he left office.

(Red Oak) -- A Red Oak man faces a drug charge following his arrest Monday afternoon. The Red Oak Police Department says 21-year-old Matthew Dillion Childs was arrested shortly after 3:30 p.m. for ...

Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned ... at the company unlawfully discriminated against white and Asian-American applicants. category Trump tariff promises ...